Company of Biologists
|Agreement labeling||Company of Biologists Read & Publish agreement|
|Has the agreement been disclosed and published?||Yes|
|Agreement period||01/01/2023 – 12/31/2025|
|Consortia / Institution||IReL|
Approximate range of annual corresponding author publications
|Comments on size/article output||Low article output with CoB, less than 5 articles per year|
How do the costs of the agreement relate to previous subscription-only agreements with the publisher?
Transfomative agreements vary by their transformative mechanisms, meaning the way in which financing is shifted from the subscription side to open access publishing. What are the characteristics of this agreement to this regard?
|Subscriptions fully converted to OA publishing fees (access related costs 5% or less)|
How do entitlements for open access publishing correlate to the anticipated article output? Which mechanisms for risk sharing have been agreed in cases of exceeding or not reaching the number of OA publishing entitlements?
|No risk sharing, uncapped, unlimited OA publishing|
Are all journals relevant to your affiliated authors (in which you expect them to publish) eligible for OA publishing under the agreement?
|Are fully open access journals covered by the agreement?||Yes|
|OA LICENSE||CC-BY mandatory|
||Original research articles|
What is the approximate share of access related costs of the overall agreement?
|More than 50%|
Are all read relevant journals covered by the agreement?
|PERPETUAL ACCESS RIGHTS||No|
|OVERALL ASSESSMENT AND COMMENTS||Workflow still being refined|
|Request contact to the licensee||contact [at] esac-initiative [dot] org|